Scarica l'app Stockscreener
0.1475
3.15%
-0.0048
Pre-mercato:
.13
-0.0175
-11.86%
Precedente Chiudi:
$0.1523
Aprire:
$0.1507
Volume 24 ore:
2.30M
Relative Volume:
0.35
Capitalizzazione di mercato:
$5.38M
Reddito:
-
Utile/perdita netta:
$-48.85M
Rapporto P/E:
-0.0639
EPS:
-2.31
Flusso di cassa netto:
$-46.25M
1 W Prestazione:
-13.59%
1M Prestazione:
-28.78%
6M Prestazione:
-77.31%
1 anno Prestazione:
-86.21%
Intervallo 1D:
$0.1404
$0.152
Intervallo di 1 settimana:
$0.1395
$0.1743
Portata 52W:
$0.1395
$9.3722
Vincerx Pharma Inc Stock (VINC) Company Profile
Nome
Vincerx Pharma Inc
Settore
Industria
Telefono
650-800-6676
Indirizzo
260 SHERIDAN AVENUE, PALO ALTO
Confronta VINC con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
VINC
Vincerx Pharma Inc
|
0.1475 | 5.38M | 0 | -48.85M | -46.25M | -2.31 |
|
VRTX
Vertex Pharmaceuticals Inc
|
427.89 | 110.19B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
687.80 | 75.58B | 13.85B | 4.65B | 3.32B | 40.41 |
|
ARGX
Argen X Se Adr
|
647.39 | 38.71B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
264.99 | 34.18B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
117.25 | 28.11B | 3.30B | -501.07M | 1.03B | -2.1146 |
Vincerx Pharma Inc Stock (VINC) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2022-01-14 | Iniziato | H.C. Wainwright | Buy |
| 2021-12-23 | Iniziato | Cantor Fitzgerald | Overweight |
| 2021-11-01 | Iniziato | SVB Leerink | Outperform |
| 2021-09-13 | Iniziato | Laidlaw | Buy |
| 2021-08-25 | Iniziato | B. Riley Securities | Buy |
Vincerx Pharma Inc Borsa (VINC) Ultime notizie
Vincerx Pharma enters at-the-market equity offering deal - MSN
Vincerx Pharma enters at-the-market equity offering deal By Investing.com - Investing.com UK
Vincerx Pharma ends sales agreement, approves reverse stock split - MSN
VINC Stock Touches 52-Week Low at $0.17 Amid Market Challenges - Investing.com UK
SHAREHOLDER NOTICE: Halper Sadeh LLC Investigates GETY, CLBR, VINC, NEUE on Behalf of Shareholders - GlobeNewswire Inc.
Investor law firms question biotech merger's 'fairness' - The Business Journals
What Did We Find About Insider Trading At Vincerx Pharma Inc (NASDAQ: VINC)? - Stocks Register
SHAREHOLDER NOTICE: Halper Sadeh LLC Investigates VINC, MHLD, NEUE on Behalf of Shareholders - Stockhouse Publishing
VINCERX PHARMA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Vincerx Pharma, Inc.VINC - Marketscreener.com
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates VINC, NEUE, ZUO on Behalf of Shareholders - Stockhouse Publishing
Vincerx Pharma Inc (NASDAQ: VINC): On Track To A Higher Share Price - Stocks Register
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates JWN, VINC, OMIC on Behalf of Shareholders - The Malaysian Reserve
$TOCKHOLDER ALERT: The M&A Class Action Firm Is Investigating the MergerVINC, VCSA, MRNS, MHLD - Markets Insider
VINC Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Vincerx Pharma, Inc. Is Fair to Shareholders - Business Wire
Stock market today: Intrusion surged by 123.33% while Snow Lake Resources plunged by 21.88% in early trading - Business Upturn
Shareholder Alert: Ademi LLP Investigates Whether Vincerx Pharma, Inc. Is Obtaining a Fair Price for Its Public Shareholders - Business Wire
Vincerx Pharma Stock Rises On Proposed Merger With Oqory: Retail Remains Bullish - MSN
Why Vincerx Pharma Shares Are Trading Higher By Around 64%; Here Are 20 Stocks Moving Premarket - Benzinga
Vincerx Pharma Announces Merger, Leadership Changes, and Financing - TipRanks
Vincerx Pharma To Be Acquired by Private Biotech, Cut Headcount - MarketWatch
Vincerx Pharma enters binding term sheet for merger with Oqory - TipRanks
Psyence Biomed Announces Closing of $2.0 Million Private Placement - The Manila Times
Vincerx Pharma Enters into a Binding Term Sheet for a Strategic Merger with Oqory, Inc. - GlobeNewswire
VINC Stock Touches 52-Week Low at $0.18 Amid Market Challenges - Investing.com UK
FDA Approvals News Live Feed - StockTitan
Canadian Solar (NASDAQ:CSIQ) Shares Gap Up – Here’s What Happened - Defense World
Bicycle Therapeutics (NASDAQ:BCYC) Shares Gap Down Following Analyst Downgrade - Defense World
Vincerx Pharma, Inc. (NASDAQ:VINC) Short Interest Update - Defense World
WaFd, Inc (NASDAQ:WAFDP) Short Interest Down 23.6% in November - Defense World
Vinci Partners Investments Ltd. (NASDAQ:VINP) Sees Significant Growth in Short Interest - Defense World
Full Stock Market News from 2024-12-14 - StockTitan
Vincerx Pharma announces workforce reduction of 55%, cost-control measures - Yahoo Finance
VINC Stock Touches 52-Week Low at $0.24 Amid Market Challenges - Investing.com UK
Vincerx Pharma Stock Gets Retail Followers Buzzing With Big Layoff Plans To Sustain Cancer Drug Trials - Asianet Newsable
Vincerx Pharma to Implement Cost-Controls to Support Advancing Phase 1 Study of Vip943 - Marketscreener.com
Vincerx Pharma to Implement Cost-Controls to Support Advancing Phase 1 Study of VIP943 - GlobeNewswire
Vincerx Pharma Reports Promising Cancer Drug Results, Explores Strategic Options Amid Cost Cuts - StockTitan
DelveInsight Business Research, LLP: Follicular Lymphoma Clinical Trial Pipeline Appears Robust With 50+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight - finanznachrichten.de
Companies To Watch: Terns Pharmaceuticals - Life Science Leader Magazine
Vincerx Pharma gets extension to meet Nasdaq listing criteria - Investing.com
Vincerx Pharma gets extension to meet Nasdaq listing criteria By Investing.com - Investing.com UK
Recursion Completes Exscientia Merger, Creates AI Drug Discovery Powerhouse with $20B+ Pipeline - StockTitan
Leerink Partnrs Weighs in on Vincerx Pharma FY2024 Earnings - Defense World
ARMISTICE CAPITAL, LLC Expands Stake in Vincerx Pharma Inc - GuruFocus.com
Vincerx Pharma Inc (VINC) Quarterly 10-Q Report - Quartz
Prosight Management, LP Reduces Stake in Vincerx Pharma Inc - GuruFocus.com
Vincerx Pharma Reports Q3 2024 Financial Results - TipRanks
Vincerx Pharma Inc reports results for the quarter ended September 30Earnings Summary - XM
Vincerx Pharma Inc Azioni (VINC) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
4.81%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):